首页> 外文期刊>International immunology. >A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions.
【24h】

A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions.

机译:表达高内皮小静脉的混杂趋化因子受体DARC可以结合炎症而不是淋巴样趋化因子,并且在生理条件下可用于淋巴细胞归巢。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Chemokines displayed on the luminal surface of blood vessels play pivotal roles in inflammatory and homeostatic leukocyte trafficking in vivo. However, the mechanisms underlying the functional regulation of chemokines on the endothelial cell surface remain ill-defined. A promiscuous chemokine receptor, the Duffy antigen receptor for chemokines (DARC), has been implicated in the regulation of chemokine functions. Here we show that DARC is selectively expressed at the mRNA and protein levels in the high endothelial venules (HEV) of unstimulated lymph nodes (LN). To examine the biological significance of DARC expression in HEV, we performed competitive binding experiments with 20 different chemokines. The results showed that DARC selectively bound distinct members of the pro-inflammatory chemokines such as CXCL1, CXCL5, CCL2, CCL5 and CCL7, but not lymphoid chemokines such as CCL21, CCL19, CXCL12 and CXCL13 that are normally expressed in HEV. CCL2 bound to DARC failed to induce a significant cytosolic [Ca(2+)] elevation in CCR2B-expressing cells, whereas the free form of CCL2 induced a distinct [Ca(2+)] elevation, suggesting that DARC down-regulates activities of pro-inflammatory chemokines upon binding. Targeted disruption of the gene encoding DARC did not induce any obvious changes in the cell number or leukocyte subsets in the peripheral and mesenteric LN. Neither did DARC deficiency significantly affect lymphocyte migration into LN. These results suggest that DARC may be a scavenger for pro-inflammatory chemokines, but not a presenting molecule for lymphoid chemokines at HEV and that it is probably functionally dispensable for lymphocyte trafficking to HEV-bearing lymphoid tissues under physiological conditions.
机译:血管腔表面显示的趋化因子在体内炎症和体内稳态白细胞运输中起关键作用。但是,内皮细胞表面趋化因子功能调节的基础机制仍然不清楚。混杂的趋化因子受体,趋化因子的达菲(Duffy)抗原受体(DARC),已经参与了趋化因子功能的调节。在这里,我们显示DARC在不受刺激的淋巴结(LN)的高内皮小静脉(HEV)中在mRNA和蛋白水平选择性表达。为了检查DARC在HEV中的生物学意义,我们使用20种不同的趋化因子进行了竞争性结合实验。结果表明,DARC选择性结合促炎趋化因子的不同成员,例如CXCL1,CXCL5,CCL2,CCL5和CCL7,但不结合淋巴趋化因子,例如在HEV中正常表达的CCL21,CCL19,CXCL12和CXCL13。绑定到DARC的CCL2未能在表达CCR2B的细胞中诱导明显的胞质[Ca(2+)]升高,而自由形式的CCL2诱导了明显的[Ca(2+)]升高,表明DARC下调了CCR2的活性。结合后促炎趋化因子。靶向编码DARC的基因的靶向破坏并未诱导外周和肠系膜LN中细胞数量或白细胞亚群的任何明显变化。 DARC缺乏症也没有显着影响淋巴细胞向LN的迁移。这些结果表明,DARC可能是促炎性趋化因子的清除剂,而不是HEV淋巴趋化因子的递呈分子,并且在生理条件下,它可能在功能上对于淋巴细胞向携带HEV的淋巴组织的运输是可有可无的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号